- Drug Eluting Absorbable Nasal Implant Devices
- Non-Drug Eluting Nasal Implants Devices
Absorbable Nasal Implant Devices Market size was valued at USD 578 million in 2022 and is poised to grow at a significant CAGR of 6.8% from 2023-2029. Absorbable Nasal implant is a device that supports the nasal cartilage while enhancing breathing for people suffering from nasal blockage. The implants help to treat nasal obstructions or collapse of the nasal valve, also known as vestibular stenosis, caused by a number of reasons, including larger turbinates, septal deviation, and weak upper and lower lateral cartilage of the nasal wall. According to CDC, in U.S. about 28.9 million adults suffer from sinusitis making up about 11.6% of the adult population. The prevalence of medical conditions of chronic sinusitis, polyps, and nonallergic rhinitis and the shifting preference of people for nose reshaping or rhinoplasty is currently driving the absorbable nasal implants market. The increasing number of patients suffering from nasal valve collapse including stuffiness, and inability to breathe through one or both nostrils also boost the market. Over 80% of the overall airway resistance is caused by the nasal valve collapsing. Around 1 million treatments are performed to relieve the symptoms of nasal blockage, and over 3 million Americans contact a doctor about it, further increasing the market value. Based on the material, the polymer segment holds the largest market owing to the increased use of polymer material in the manufacturing of absorbable nasal implants. For instance, the LATERA nasal implants are prepared from PLLA (poly-L-lactide) polymer, which is absorbed by the nasal tissues. Moreover, the development of biodegradable nasal implants, nasal dressing, and further development of technology has opened up several opportunities for the development of the market. But the growing number of health and procedural risks associated with nasal surgery like nosebleeds, bursting of small blood vessels under the skin, and nerve damage may hinder the adoption of absorbable nasal implants hindering the growth of the market. However, the increasing demand for nasal implants for medical and aesthetic conditions, rising medical emergency nasal surgery, and growing demand for cosmetic surgeries have positively impacted the absorbable nasal implants market and are expected to expand in the forecasted period.
Absorbable Nasal Implant Devices Market Key Developments:
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increase in the R&D for the innovation of novel absorbable nasal implants with advanced technologies such as decreased irritation & side effects spurs the absorbable nasal implant devices market over the forecast period. Moreover, rise in demand for absorbable nasal implants to avoid secondary surgery, adoption of advanced implants by physicians, relief from nasal congestion, and enhanced respiration ability are bolster the absorbable nasal implant devices market. However, stringent regulatory policies for product approval, product recall, mild pain and irritation with devices, and lack of awareness about absorbable implants among key stakeholders are expectd to restrain the growth of the market over the forecast years.
The absorbable nasal implant devices market size was valued at USD 578 million in 2022
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The absorbable nasal implant devices market key players are Smith & Nephew plc (U.K.) Pfizer, Inc. (U.S.) Intersect ENT, Inc. (U.S.) ArthroCare Corporation (Smith & Nephew, Inc.) (U.S.) Spirox, Inc. (Entellus Medical) (U.S.)
1.Executive Summary |
2.Global Absorbable Nasal Implant Devices Market Introduction |
2.1.Global Absorbable Nasal Implant Devices Market - Taxonomy |
2.2.Global Absorbable Nasal Implant Devices Market - Definitions |
2.2.1.Product Type |
2.2.2.Material Type |
2.2.3.End User |
2.2.4.Region |
3.Global Absorbable Nasal Implant Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Absorbable Nasal Implant Devices Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Absorbable Nasal Implant Devices Market By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Drug Eluting Absorbable Nasal Implant Devices |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Non-Drug Eluting Nasal Implants Devices |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Absorbable Nasal Implant Devices Market By Material Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Polymer |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Carboxy Methyl Cellulose (CMC) |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Others |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Absorbable Nasal Implant Devices Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Clinics |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Ambulatory Surgical Centers |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Absorbable Nasal Implant Devices Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Absorbable Nasal Implant Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Drug Eluting Absorbable Nasal Implant Devices |
9.1.2.Non-Drug Eluting Nasal Implants Devices |
9.2. Material Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Polymer |
9.2.2.Carboxy Methyl Cellulose (CMC) |
9.2.3.Others |
9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Clinics |
9.3.3.Ambulatory Surgical Centers |
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Absorbable Nasal Implant Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Drug Eluting Absorbable Nasal Implant Devices |
10.1.2.Non-Drug Eluting Nasal Implants Devices |
10.2. Material Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Polymer |
10.2.2.Carboxy Methyl Cellulose (CMC) |
10.2.3.Others |
10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Clinics |
10.3.3.Ambulatory Surgical Centers |
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11.Asia Pacific (APAC) Absorbable Nasal Implant Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Drug Eluting Absorbable Nasal Implant Devices |
11.1.2.Non-Drug Eluting Nasal Implants Devices |
11.2. Material Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Polymer |
11.2.2.Carboxy Methyl Cellulose (CMC) |
11.2.3.Others |
11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Clinics |
11.3.3.Ambulatory Surgical Centers |
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Absorbable Nasal Implant Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Drug Eluting Absorbable Nasal Implant Devices |
12.1.2.Non-Drug Eluting Nasal Implants Devices |
12.2. Material Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Polymer |
12.2.2.Carboxy Methyl Cellulose (CMC) |
12.2.3.Others |
12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Clinics |
12.3.3.Ambulatory Surgical Centers |
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Absorbable Nasal Implant Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Drug Eluting Absorbable Nasal Implant Devices |
13.1.2.Non-Drug Eluting Nasal Implants Devices |
13.2. Material Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Polymer |
13.2.2.Carboxy Methyl Cellulose (CMC) |
13.2.3.Others |
13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Clinics |
13.3.3.Ambulatory Surgical Centers |
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Smith & Nephew plc (U.K.) |
14.2.2.Pfizer, Inc. (U.S.) |
14.2.3.Intersect ENT, Inc. (U.S.) |
14.2.4.ArthroCare Corporation (Smith & Nephew, Inc.) (U.S.) |
14.2.5.Spirox, Inc. (Entellus Medical) (U.S.) |
14.2.6.Stryker Corporation (U.S.) |
14.2.7.Mentor Worldwide LLC (U.S.) |
14.2.8.Acclarent, Inc. (Ethicon Inc.) (U.S.) |
15. Research Methodology |
16. Appendix and Abbreviations |